Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • Obstetrics and Gynaecology
  • Obstetrics and Gynaecology News
  • OTC Access to Oral...

OTC Access to Oral Contraceptives May Improve Equitable Contraception Use: JAMA

Written By : Medha Baranwal |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2025-09-18T20:30:11+05:30  |  Updated On 18 Sept 2025 8:30 PM IST
OTC Access to Oral Contraceptives May Improve Equitable Contraception Use: JAMA
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

USA: Researchers have found in a new cross-sectional U.S. study that many individuals obtaining oral contraceptives over-the-counter had previously used no method or less-effective contraception, suggesting OTC availability could enhance equitable access.

The study, published in JAMA Network Open by Maria I. Rodriguez and colleagues from the Center for Reproductive Health Equity at Oregon Health & Science University, assessed how the introduction of non-prescription oral contraceptives is influencing contraceptive choices across diverse populations. With the U.S. Food and Drug Administration's approval of the first over-the-counter progestin-only oral contraceptive pill (OCP) in 2023, the research aimed to determine whether this pathway is reaching those who face systemic barriers to traditional healthcare.
The cross-sectional study analyzed baseline data from a national cohort of 986 participants aged 15 to 45 years who obtained OCPs between April 2024 and February 2025, either through pharmacies or online. Participants were at risk of pregnancy and were using OCPs for contraceptive purposes. Among the group, 320 individuals (32.5%) accessed their contraceptives through the OTC route, while the remainder relied on prescriptions.
The following were the key findings of the study:
  • Individuals using OTC contraceptives were more likely to face structural disadvantages.
  • Uninsured individuals comprised 31.6% of OTC users, compared with 3.5% of prescription users.
  • Rural residents were more common among OTC users (14.4% vs 8.4%).
  • Adolescents were more likely to use OTC options, showing benefits for younger groups with limited access to health services.
  • Fertility preferences did not differ significantly between OTC and prescription groups.
  • OTC access was linked to a 31.8 percentage point increase in transitioning from nonuse of contraception to an effective method compared with prescription users.
  • OTC use was associated with a 41.0 percentage point increase in shifting from less-effective methods, such as condoms or emergency contraception, to oral contraceptive pills.
The authors emphasized that these patterns illustrate how OTC availability is enabling underserved populations to access effective contraception. “By removing prescription barriers, oral contraceptives are reaching individuals who might otherwise remain unprotected against unintended pregnancies,” the researchers noted.
While the findings emphasize the promise of OTC contraceptives, the authors also stressed the importance of broader awareness and supportive policies. Insurance reimbursement for OTC contraceptives and educational efforts to inform communities about their availability will be crucial for sustaining equitable access.
The study demonstrates that OTC oral contraceptives are not only increasing uptake among individuals at risk of unintended pregnancy but are also serving populations that historically face barriers to reproductive health care, including adolescents, uninsured individuals, and those living in rural areas. As restrictions on reproductive health care continue to evolve across the U.S., expanding OTC access offers a practical and impactful strategy to promote reproductive autonomy and reduce disparities in contraceptive use.
Reference:
Rodriguez MI, Burns H, Sheridan R, Edelman AB. Over-the-Counter Oral Contraceptive Use and Initiation of Contraception. JAMA Netw Open. 2025;8(8):e2527438. doi:10.1001/jamanetworkopen.2025.27438


JAMA Network OpenContraceptionOral Contraceptive
Source : JAMA Network Open
Medha Baranwal
Medha Baranwal

    MSc. Biotechnology

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Ramiven: The only CDK4/6i that Delivers Proven and Deepening Protection After a 2-year Treatment Period

    Ramiven: The only CDK4/6i that Delivers Proven and Deepening Protection After a 2-year Treatment...

    Optimising Type 2 Diabetes Outcomes through Dapagliflozin and Sitagliptin FDC: A Gluco-Cardio-Renal Perspective

    Optimising Type 2 Diabetes Outcomes through Dapagliflozin and Sitagliptin FDC: A Gluco-Cardio-Renal...

    WHO Issues First Global Guideline on Diabetes in Pregnancy on World Diabetes Day 2025: Key Takeaways

    WHO Issues First Global Guideline on Diabetes in Pregnancy on World Diabetes Day 2025: Key Takeaways

    PRIME-Vilda Trial Results Highlights Vildagliptin SRs Efficacy and Safety in Indian Type 2 Diabetes Patients on Metformin

    PRIME-Vilda Trial Results Highlights Vildagliptin SR's Efficacy and Safety in Indian Type 2 Diabetes...

    Real-World Evidence in Psoriatic Arthritis: PRO-SPIRIT Study

    Real-World Evidence in Psoriatic Arthritis: PRO-SPIRIT Study

    View All

    Journal Club Today

    Ramiven: The only CDK4/6i that Delivers Proven and Deepening Protection After a 2-year Treatment Period

    Ramiven: The only CDK4/6i that Delivers Proven and Deepening Protection After a 2-year Treatment...

    View All

    Health News Today

    Health Bulletin 28/November/2025

    Health Bulletin 28/November/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok